Research indicates that a test of AQP1 and PLIN2 levels in urine may act as an indicator of early stage renal cell carcinoma (RCC).
The t(11;14) translocation was associated with poorer response rates and shorter overall survival in patients treated with bortezomib-based regimens.
[Cancer Control] Platelet transfusion can often be a vital aspect aspect of managing cancer, as treatment courses can weaken the function of the cells requires to stop bleeding.
A presentation from the 249th ACS Meeting highlights the potential importance of vitamin D levels for patients with prostate cancer.
From Oncology Nurse Advisor
Sign Up for Free e-newsletters
Cancer Therapy Advisor Articles
- Lower Lung, Colorectal Cancer Risk with High Fitness Levels in Midlife Men
- Nivolumab Safer, More Effective Than Chemo for Advanced Melanoma
- Nivolumab May Be Safe, Effective for Previously Treated Kidney Cancer
- Vitamin D May Help Combat Low-Grade Prostate Tumors
- Early Initiation of Palliative Care Improves 1-Year Survival
- Sunitinib May Be Acceptable First Line Treatment for Metastatic Renal Cell Carcinoma
- Minimal Benefit with Bortezomib, Dexamethasone as Maintenance Therapy for Multiple Myeloma
- Vorinostat May Not Improve Survival in Mesothelioma
- High Fish Intake Linked to Survival After Breast Cancer
- New, Less Aggresssive Guidelines for Pancreatic Cysts
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|